Adrien Peyrache.

Adrien Peyrache

Associate professor of neurology and neurosurgery
McGill University’s Montreal Neurological Institute

Adrien Peyrache is associate professor of neurology and neurosurgery at McGill University’s Montreal Neurological Institute, joining the institution in 2016. He holds the Canadian Research Chair in Systems Neuroscience and has significantly contributed to understanding memory and spatial navigation, particularly regarding the coordination of neurons during sleep to support memory formation.

As an active proponent of open science, Peyrache co-founded—and, until 2022, chaired—the selection committee of The Neuro – Irv and Helga Cooper Foundation Open Science Prize. He serves on the reviewing editorial board of eLife, and in 2024 he co-founded the Quebec Sleep Research Network, where he is co-director.

Peyrache completed his undergraduate studies at ESPCI-Paris Sciences et Lettres University and obtained a master’s degree in cognitive science at Ecole Normale Supérieure, followed by a Ph.D. in neuroscience at the College de France. For his postdoctoral training, he first worked with Alain Destexhe at the CNRS and then joined the lab of Gyorgy Buzsaki at New York University.

Explore more from The Transmitter

Research image of cell-surface protein LPHN2.

‘Push-pull’ recipe for neural wiring used in multiple brain regions

A versatile pair of proteins steers neurons toward their targets and helps establish the brain’s sensory maps, new studies suggest.

By Holly Barker
5 June 2026 | 5 min read
Research image showing dopamine level spikes.

Reward-learning algorithm hardwired into dopamine circuit

The finding bolsters the canonical model of reward prediction error, which has come under scrutiny in recent years.

By Natalia Mesa
5 June 2026 | 5 min read
Burke Neurological Institute.

Exclusive: Brain and spinal cord institute halts research, citing funding problems

The Burke Neurological Institute, which calls itself “the only research institute in the U.S. dedicated to finding treatments to repair the brain and spinal cord,” ceased research operations on 22 May.

By Lauren Schenkman
4 June 2026 | 5 min read